$89.00
Reta, also known as Retatrutide, is a synthetic investigational peptide developed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is currently being studied for its potential effects on weight management, glucose regulation, and metabolic health in preclinical and clinical research models. By activating multiple incretin and glucagon receptors, Retatrutide demonstrates broad systemic effects that are under investigation for their relevance in metabolic and endocrine research.
All compounds supplied by Origin Research are intended strictly for laboratory, analytical, and in-vitro research use. They are not for human consumption, medical use, therapeutic application, or diagnostic purposes.
Yes. Every batch is accompanied by a batch-specific Certificate of Analysis. COAs document purity percentage, testing methodology, and batch reference. No generic or reused reports are provided.
